Floatz logo

Fludarabine

Acute Leukemia

Sawa Ito, MDSmall moleculePhase 2/3Active
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
67/ 100
Competitive Position
73/ 100

Competitive context

59 Active assets in the Acute Leukemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Sawa Ito, MD
Phase 4BB
Cytosin-Arabinosid
Janssen Research & Development, LLC
Phase 2/3BB
METHOTREXATE
SWOG Cancer Research Network
Phase 3BB
ETOPOSIDE
Nanfang Hospital, Southern Medical University
Phase 2/3BB
Busulphan
Sawa Ito, MD
Phase 4BB

View all 50 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →